Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0034546
Title: Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma
Authors: Creighton C.J.
Hernandez-Herrera A.
Jacobsen A. 
Levine D.A.
Mankoo P.
Schultz N.
Du Y.
Zhang Y.
Larsson E.
Sheridan R.
Xiao W.
Spellman P.T.
Getz G.
Wheeler D.A.
Perou C.M.
Gibbs R.A.
Sander C.
Hayes D.N.
Gunaratne P.H.
Keywords: microRNA
microRNA
MIRN29 microRNA, human
3' untranslated region
5' untranslated region
article
cancer grading
cell proliferation
cell viability
controlled study
copy number variation
DNMT3A gene
DNMT3B gene
gene expression profiling
gene overexpression
genetic algorithm
genetic database
genetic heterogeneity
genetic transcription
hemizygosity
human
human cell
human tissue
in vitro study
oncogene
ovary carcinoma
overall survival
RNA methylation
serosa
breast
female
gene expression regulation
genetics
metabolism
neoplasm
ovary tumor
pathology
tumor cell line
3' Untranslated Regions
Breast
Cell Line, Tumor
DNA Copy Number Variations
Female
Gene Expression Regulation, Neoplastic
Humans
MicroRNAs
Neoplasms, Cystic, Mucinous, and Serous
Ovarian Neoplasms
Issue Date: 2012
Publisher: Public Library of Science
Citation: Creighton C.J., Hernandez-Herrera A., Jacobsen A., Levine D.A., Mankoo P., Schultz N., Du Y., Zhang Y., Larsson E., Sheridan R., Xiao W., Spellman P.T., Getz G., Wheeler D.A., Perou C.M., Gibbs R.A., Sander C., Hayes D.N., Gunaratne P.H. (2012). Integrated analyses of microRNAs demonstrate their widespread influence on gene expression in high-grade serous ovarian carcinoma. PLoS ONE 7 (3) : e34546. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0034546
Abstract: Background: The Cancer Genome Atlas (TCGA) Network recently comprehensively catalogued the molecular aberrations in 487 high-grade serous ovarian cancers, with much remaining to be elucidated regarding the microRNAs (miRNAs). Here, using TCGA ovarian data, we surveyed the miRNAs, in the context of their predicted gene targets. Methods and Results: Integration of miRNA and gene patterns yielded evidence that proximal pairs of miRNAs are processed from polycistronic primary transcripts, and that intronic miRNAs and their host gene mRNAs derive from common transcripts. Patterns of miRNA expression revealed multiple tumor subtypes and a set of 34 miRNAs predictive of overall patient survival. In a global analysis, miRNA:mRNA pairs anti-correlated in expression across tumors showed a higher frequency of in silico predicted target sites in the mRNA 3?-untranslated region (with less frequency observed for coding sequence and 5?-untranslated regions). The miR-29 family and predicted target genes were among the most strongly anti-correlated miRNA:mRNA pairs; over-expression of miR-29a in vitro repressed several anti-correlated genes (including DNMT3A and DNMT3B) and substantially decreased ovarian cancer cell viability. Conclusions: This study establishes miRNAs as having a widespread impact on gene expression programs in ovarian cancer, further strengthening our understanding of miRNA biology as it applies to human cancer. As with gene transcripts, miRNAs exhibit high diversity reflecting the genomic heterogeneity within a clinically homogeneous disease population. Putative miRNA:mRNA interactions, as identified using integrative analysis, can be validated. TCGA data are a valuable resource for the identification of novel tumor suppressive miRNAs in ovarian as well as other cancers. © 2012 Creighton et al.
Source Title: PLoS ONE
URI: https://scholarbank.nus.edu.sg/handle/10635/165573
ISSN: 19326203
DOI: 10.1371/journal.pone.0034546
Appears in Collections:Elements
Staff Publications

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0034546.pdf908.07 kBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.